In invasive carcinomas, we identified two groups with respect to the c-MYC and SIRT1 levels: One group comprised four cases (45%) which displayed negative to low c-MYC expression (Figure 4e) and negative SIRT1 staining (Figure 4f). This evidence concerns the gene MYC and invasive carcinoma.